Diagnostic Imaging 2020 Global Market Key Players, Analysis and Forecast to 2023

 

Market Highlights:

Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder. The continues increase in geriatric population, increasing prevalence of chronic diseases, and  technological advancements are the major factors driving the growth of the globaldiagnostic imaging market. Additionally, increasing investment in R&D and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market. For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare  for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and north America .

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6683 

The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period.

Regional Analysis:

The market in the Americas is expected to dominate the global diagnostic imaging market during the forecast period due to the increasing number of patients suffering from chronic diseases,  surge in geriatric population, rising prevalence of cancer, and well-established healthcare system

The European market is expected to hold the second position in the global diagnostic imaging market owing to the government support and favorable regulatory policies, increasing medical and diagnostic centers, and increasing healthcare expenditure. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing population and subsequently increasing chronic diseases, rising investment in healthcare and increase in disposable income. The market in the Middle East & Africa is likely to hold  the smallest share of the global diagnostic imaging market.

Segmentation:

The global diagnostic imaging market has been segmented on the basis of product, source, and application.

Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products

The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications

The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.     

Key Players:

Some of the key players in the global diagnostic imaging market are Siemens Healthcare Private Limited, Koninklijke Philips N.V.,CANON MEDICAL SYSTEMS CORPORATION, Shimadzu Corporation, Carestream Health,Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation,FUJIFILM Holdings Corporation, Hitachi Medical Systems, and Hologic Inc.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/diagnostic-imaging-market

Abetalipoproteinemia Monitoring Systems Market Projected to Witness Vigorous Expansion by 2023

 

Abetalipoproteinemia Monitoring Systems Market – Overview:

The abetalipoproteinemia monitoring systems market is profiting as awareness regarding physiological disorders is rising and cases getting registered more and more every day. The disease is caused by a mutation in microsomal triglyceride transfer protein. It can perturb the gastrointestinal system, eyes, nervous system, and blood circulation. The disease further unsettles the normal absorption process of fat and fat-soluble vitamins from food. The global abetalipoproteinemia monitoring systems market is expecting an impressive 9.8% CAGR during the forecast period (2018-2023).

In the process, the market can also scale its valuation to USD 147 million by 2023, claims Market Research Future (MRFR). The report further encompasses market drivers such as supportive treatment that backs the treatment properly, along with, well-structured diagnostic treatment facility.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6683 

On reverso, the disease is so rare that a substantial patient pool to support the abetalipoproteinemia monitoring systems market growth seems to be a far-fetched plan. Furthermore, vision loss is a problem that can deter many from availing the necessary treatment. However, gene therapy treatment is advancing significantly and can steer away from the abetalipoproteinemia monitoring systems market from sluggish growth in the coming years.       

Abetalipoproteinemia Monitoring Systems Market – Competition Insight:

The abetalipoproteinemia monitoring systems market is banking mostly on the strategies implemented by prominent companies with significant market impact. These tactics, not only help in individual sustenance but assists in expansion for the market as a whole. Merger, acquisition, collaboration, product launch, and other methods are few examples of such extensive procedures that are bound to impact the market.

Major market influencers of the abetalipoproteinemia monitoring systems market are Lonza, Piramal Pharma Solutions, Abbott Laboratories, Koninklijke DSM N.V., and Barrington Nutritionals.

Abetalipoproteinemia Monitoring Systems Market – Segmentation:

The global abetalipoproteinemia monitoring systems market can be segmented by diagnosis, blood testing treatment, and end-user.

Diagnosis-wise, the abetalipoproteinemia monitoring systems market includes molecular genetic testing and blood testing. Molecular genetic testing has the maximum market share and is expected to grow further with the fastest CAGR during the forecast period.  

Based on blood testing treatment, the abetalipoproteinemia monitoring systems market consists fat-soluble vitamins supplementation and others. Fat-soluble vitamins supplementation is taking charge of the segment.

Based on end-user, the abetalipoproteinemia monitoring systems market comprises hospitals & clinics, diagnostics lab, and others. Hospitals & clinics segment fetch in the maximum revenue.

Abetalipoproteinemia Monitoring Systems Market – Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA) are prominent regions on the basis of which the report on abetalipoproteinemia monitoring systems market has been made.

The Americas can be further segmented into North and South America. North America includes the U.S. and Canada, two countries with superlative medical facilities. Medical infrastructure and reimbursement policies are quite supportive. However, the disease is so rare that a substantial growth based is highly unlikely. The region can expect moderate growth during the forecast period.

Europe shares similar features with the market of the Americas. Its research and development facilities are quite astounding and, like the Americas, Europe too has several companies based out of the region to support the market expansion.

The APAC is the new booming market. Medical tourism is gaining popularity and infrastructure in many countries are getting revamped owing to which the region can record significant growth. Furthermore, just like the MEA market, the region has several countries with huge population suffering from malnutrition which is also a major trigger for abetalipoproteinemia.

Industry Updates:

March 21, 2018: Designed for seniors, TruSense, a smart home monitoring solution, has recently announced that it has added its first-ever smart personal emergency response pendant which combine GPS with notification when it is not being worn, thus extending protection even when outside the home. TruSense GPS Smart Pendant works in combination with TruSense Home. The combination offers customized alerts whenever the pendant is not being worn, thereby eradicating all the false sense of security created.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/abetalipoproteinemia-monitoring-systems-market-6683 

Global Medical Pendant Market is Expected to Experience Immense Growth During 2020 – 2023

 

Medical Pendant Market – Overview:

The Global Medical Pendant Market is presumed to garner USD 149.01 million during the forecast period (2017-2023). The market is anticipated to register 7% CAGR owing to the technological advancements, asserts Market Research Future (MRFR). Medical pendant is referred to as a wireless device which is designed to alert the healthcare professionals about the occurrence of any hazard or emergency which require immediate attention. A medical pendant system is usually installed on the ceiling of a hospital with a strong body system which is built of supporting rods and stainless-steel extensions. They are compact with customizable configurations to fulfill the requirements of healthcare centers and hospitals.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6681 The growing need for low-risk and safe workspace for medical workforce is fueling the global medical pendant market during the assessment period. Technological advancements such as button-press enabled medical pendants which facilitate the system’s arm movement are further fostering the global market. Devices with multifaceted designs and ultra-flexible configurations are commercially available which focuses on fulfilling the requirements of the healthcare specialties. Such devices are expected to gain traction across the globe which is further likely to trigger the market growth in the coming years. Moreover, growing demand for medical pendants in the ICU and operating theatres are likely to spur the market growth.

On the flip side, high cost of medical pendants coupled with the lack of professional technicians are anticipated to impede the market growth in the coming years.

Medical Pendant Market – Competitive Dashboard:

The noteworthy players operating the global medical pendant market are MEDIMAXKOREA, Starkstrom, Tedisel Medical, Megasan Medikal, Surgiris, Brandon Medical Co. Ltd., BeaconMedæs, Skytron LLC, Elektra Hellas S.A., and Ondal Medical Systems GmbH.

Medical Pendant Market: Segmental Analysis:

The global medical pendant market has been segmented on the basis of product, application, and region.By mode of product, the global medical pendant market has been segmented into fixed pendants, fixed retractable pendants, single arm movable pendants, double & multi-arm movable pendants, and accessories. Among these, the fixed pendants hold the largest market share, whereas the single arm moveable pendants account for the fastest growing segment.

By mode of application, the global medical pendant market has been segmented into hospital, clinics and others. The hospital segment is further sub-segmented into intensive care unit (ICU), operating theatre (OT) & recovery room (RR), and emergency room (ER). Among these, the clinics segment is expected to be the fastest growing segment.

Medical Pendant Market – Regional Insights:

Geographically, the global medical pendant market span across major four regions, namely Europe, America, Asia Pacific, and the Middle East & Africa.

The North American region in the Americas is presumed to dominate the global medical pendant market in terms of revenue owing to the presence of world class healthcare infrastructure, advanced facilities, top notch healthcare practices, and strict mandates from the regulating authorities.

The Asia Pacific region is anticipated to account for the fastest growth owing to the rapid growth in the healthcare infrastructure, increased spending, and government initiatives and focus on better healthcare practices owing to the rising medical tourism industry.Industry Updates:

March 21, 2018: Designed for seniors, TruSense, a smart home monitoring solution, has recently announced that it has added its first-ever smart personal emergency response pendant which combine GPS with notification when it is not being worn, thus extending protection even when outside the home. TruSense GPS Smart Pendant works in combination with TruSense Home. The combination offers customized alerts whenever the pendant is not being worn, thereby eradicating all the false sense of security created.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-pendant-market-6681 

Hemodynamic Monitoring Systems Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

 The hemodynamic monitoring systems market is growing pervasively mainly due to the growing rate of cardiovascular disorders, worldwide. In the year, the hemodynamic monitoring systems market had valued at USD 780 MN which is expected to reach USD 1,054 MN by 2023, registering 7.3% CAGR during the forecast period (2017-2023).

Over the last couple of decades, incidence of diseases and disorders related to the heart and blood pressure have increased drastically. Sadly, the figure is growing every year. Although a number of precautionary measures and innovative therapies are taken care of, the prevalence of these diseases is rising continuously, becoming a major concern. Such factors are commutatively contributing to the growth of the hemodynamic monitoring systems market, globally.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6678 

Increasing technological advancements in the field of heart care drive the market growth. The global hemodynamic monitoring systems market is heading with the pervasively rising number of patients suffering from arterial diseases led by the sedentary lifestyle.

On the flip side, factors such as stringent government regulations and unfavorable reimbursement policies in some countries are acting as a headwind that is obstructing the market growth. Besides, the lack of skilled healthcare professionals is expected to the hamper the market growth. 

Hemodynamic Monitoring Systems Market – Segmentations

The global hemodynamic monitoring systems market has been segmented on the basis of product, type, end-use, and region.

By product, the market is segmented into disposables, monitors, minimally invasive, and others. Among these, the segment – monitors accounts for the largest segment.

By type, the market is segmented into invasive, non-invasive, and others. Out of these, the Invasive accounts for the major segment.

By end-user, the market is segmented into hospitals, clinics, ambulatory care centers, home care settings, and others.  The segment hospitals and clinics is the largest segment.

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa. Out of these, the Americas region dominates the market, whereas the Asia Pacific region accounts for the fastest growing region.

Hemodynamic Monitoring Systems Market – Geographical Analysis

North America accounts for the leading share in the market for the hemodynamic monitoring systems. Factors positively impacting the market growth in the region include the high per capita health care expenditures and rapid uptake of advanced technologies in the growing healthcare sector.

Moreover, the rising geriatric population along with the increasing prevalence of high/low BP, cardiovascular diseases, hypertension, and obesity issues that are leading to heart diseases & disorders are fuelling the market growth in the region.

Furthermore, the presence of well-established market players along with the growing number of patients suffering from major/minor heart issues is positively impacting the growth in the regional market.

The Europe hemodynamic monitoring systems market accounts for the second-largest market, globally.  Attributing to the increasing healthcare expenditure, availability of advanced treatment facilities, and government initiatives, the market is estimated to register a remarkable CAGR during the forecast period (2017-2023). Increasing cardiovascular issues in the region are becoming paramount concerns which, in turn, are contributing to the market growth.

The hemodynamic monitoring systems market in the Asia Pacific region is rapidly emerging as a promising market. Growing number of aging populaces alongside the prevalence of cardiac disorders growing at an alarming rate are driving the market in the region. Also, some of the other dominant factors such as the faster adoption of healthcare technology, government initiatives to improve the quality of healthcare, favorable insurance, and reimbursement policies are fostering the growth of the APAC market.

Hemodynamic Monitoring Systems Market – Key Players

Some of the market leaders profiled in the report are Argon Medica, Teleflex Incorporated, Osypka Medical, Edwards Lifesciences Corporation; PULSION Medical Systems SE, LiDCO Group plc, Cheetah Medical, Deltex Medical Group Plc., ICU Medical, Osypka Medical GmbH, CareTaker Medical, CNSystems, NI Medical, and Uscom.

Innovation, mergers & acquisitions, product launch, and regional expansion remain the key strategies for these players to maintain their market positions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hemodynamic-monitoring-systems-market-6678 

Vascular Patches Market Estimated to Witness a Staggering Growth by 2023

 The Global Vascular Patches Market is estimated to grow double fold by the end of 2023. The market is mainly driven by the burgeoning healthcare sector. In 2017, the market had valued at USD 4.1 Bn which is expected to reach USD 6.1 Bn by 2023, registering 4.1% CAGR during the forecast period (2018-2023).

Deskbound lifestyle, anxiety, stress and high consumption of junk food are the key causes of cardiovascular diseases. Sedentary lifestyle mirrors the demand for vascular surgeries and hence, patches. Moreover, the increasing number of cases of cardiovascular diseases are supporting the vascular patches market to grow rapidly.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6652 

Increasing awareness about the availability of cardiovascular surgical procedures and the emergence of robotically assisted surgeries such as coronary artery bypass, valvuloplasty, and valvular replacement are escalating the vascular patches market to greater heights.

Furthermore, the demand for optimization of efficacy and safety monitoring along with the technological advancements, are fostering the market growth, recovering patients earlier than the estimated time which is further saving the cost of the hospital stay.

Global Vascular Patches Market – Segments

The global vascular patches market has been segmented on the basis of material, application, end-user, and regions. By material, the market is segmented into biologic vascular patches and synthetic vascular patches. 

Among these, the segment biologic vascular patches account for the major segment, whereas, the synthetic vascular patches segment accounts for the fastest growing segment.

By application, the market is segmented into carotid endarterectomy and open repair of abdominal aortic aneurysms vascular bypass surgery

Out of these, the segment carotid endarterectomy accounts for the largest segment, whereas, the open repair of abdominal aortic aneurysms vascular bypass surgery is the fastest growing segment.

By end-user the market is segmented into hospitals & clinics and ambulatory surgical centers, and others.  The segment hospitals & clinics is the largest segment, whereas the ambulatory surgical centers is deemed to be the fastest growing segment.

Global Vascular Patches Market – Regional Analysis

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa. Out of these, the Americas region dominates the market, whereas the Asia Pacific region accounts for the fastest growing region.

Globally North America accounted for the largest share in the Americas vascular patches market. It is expected to grow with a substantial CAGR during the forecast period. Rising prevalence of cardiovascular diseases in the U.S. and Canada along with the high per capita healthcare spending and the growing population are expected to spur the growth of this vertical in the region. Moreover, the rapid uptake of advanced technologies and devices in the surgical process is also an essential driver of the market. The presence of the major manufacturers is fueling the market in the region.

The European region accounts for the second-largest market for vascular patches owing to the factors such as the high per capita healthcare expenses and raising awareness towards advancements in vascular procedures and patches, positively impact the market growth in the region.  Also, the resurging economy is playing a vital role in increasing the market value in the region.

Whereas, the Asia Pacific region is emerging as the fastest growing market for vascular patches. Factors such as the growing healthcare sector in highly populated countries such as India and China substantiate the market growth in the region.  Furthermore, factors like the increasing geriatric populace, rising cases of patients suffering from chronic coronary diseases, growing awareness about healthcare, influence the market growth positively.

Global Vascular Patches Market – Key Players

Some of the market leaders profiled in the report are C.R. Bard, Inc. (U.S.), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Maquet (Germany), LeMaitre Vascular, Inc. (U.S.), W. L. Gore & Associates, Inc. (US), CryoLife, Inc. (U.S.), Admedus (Australia), Labcor Laboratórios Ltda (Brazil), Edwards Lifesciences Corporation (U.S.), and Baxter International Inc. (U.S.).

Innovation, mergers & acquisitions, product launch, and regional expansion remain the key trends for these players to maintain their market positions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/vascular-patches-market-6652 

Genotyping Market Plying for Significant Growth During 2020 - 2023

 Market Highlights

Genotyping is a procedure commonly used in healthcare and life sciences research activities. Genotyping is a genetic mapping of an organism which includes DNA sequencing and analysis of sequenced DNA. The surge in cases of genetic disorders, increasing demand for personalized medicines, and technological advancement are the factors that are propelling the growth of the market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in January 2018, Illumina, Inc. launched iSeq 100 Sequencing System in the market, the product contains sequencing by synthesis (SBS) along with the complementary metal-oxide-semiconductor (CMOS) detection technology which is easy to use and compact product.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6635 

The unfavorable reimbursement policies, the dearth of technicians, and continues change in technology are likely to hinder market growth during the forecast period.

Regional Analysis

The market in the Americas is expected to dominate the global genotyping market during the forecast period owing to the rising demand for personalized medicines, growing research and development sector, increasing cases of genetic disorders, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, rising investment into research and development by pharmaceutical companies, and increasing government initiatives for development of healthcare sector. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing disposable income, supportive government policies, and rising investment by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global genotyping market.

Segmentation

The Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.

The technology segment has been segregated into sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.

On the basis of product, the market has been divided into reagents and kits, instruments, and services.

 The market, by application, has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.

The end-user segment has been classified into hospitals, diagnostic centers, academic institutes, and research and development centers.

Key Players

Some of the key players in the global genotyping market are F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, Inc., Illumina, Inc, Fluidigm Corporation, General Electric Company, Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, and Beckman Coulter, Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/genotyping-market-6635

Ultrasound Probe Disinfection Market - Factors Driving Growth Post 2023

 Market Highlights 

The Ultrasound Probe Disinfection Market is expected to witness tremendous growth owing to the rising demand for disinfectant probes in hospitals, increasing cases of bacterial infection in healthcare center during the treatment, and increasing implementation of high-level disinfection process for critical ultrasound probes. The global ultrasound probe disinfection market was estimated USD 314.1 million in 2018 and expected to reach USD 819.1 million by 2023 at a healthy CAGR of 21.1% by 2023.

However, factors such as high cost of switching, maintenance cost for the ultrasonic instrument may hinder the market growth during the forecast period. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6642 

Segmentation

The Global Ultrasound Probe Disinfection Market is segmented on the basis of product, probe type, by process and end-user. The ultrasound probe disinfection market, by product, is segmented into instrument, service, and consumables. The instrument is segmented into automated probe reprocessors, UV-C disinfectors, manual reprocessors/soaking stations, and ultrasound transducer storage cabinets. The consumables are sub-segmented into formulation, type of disinfectants, and detergents. The disinfectants, by formulation, is segmented into disinfectant wipes, disinfectant liquids, and disinfectant sprays. By type, consumables are segmented into high-level disinfectants, and intermediate/low-level disinfectants and detergents are segmented into enzymatic detergents and non-enzymatic detergents.

By probe type the market is segmented into linear transducers, convex transducers, phased array transducers, endocavitary transducers, transesophageal echocardiography transducers| (TEE), and other. On the basis of process, the market is segmented into high-level disinfection and intermediate/low-level disinfection. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and others. 

Regional Analysis

The Americas leads in the market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in ultrasound probe disinfection and growing healthcare expenditure. According to the Consumer Report Organization and Centers for Disease Control and Prevention (CDC)  July 2015 publication, it is estimated that every year approximately 648,000 patients in the US got infected by bacteria during a hospital stay, and around 75,000 died. The increasing incidences of bacterial infection may support this market positively.

Europe is the second largest ultrasound probe disinfection market during the forecast period due to increasing prevalence of human papillomavirus (HPV). The human papillomavirus is a skin to skin transmitted disease. According to the Oxford Vaccine group fact sheet, HPV infection causes cervical cancers. It was also reported that 99% of cervical cancers are caused by the Human Papillomavirus (HPV) infection. Furthermore, it was also maintained that 3,126 new cases of cervical cancer were reported in the UK in 2015. The increasing prevalence of HPV infection supports the market growth in this region.

Asia-Pacific was estimated to be the fastest growing region for the global ultrasound probe disinfection market in 2017. The market is expected to witness high growth owing to the rising prevalence of bacterial infections. The Middle East and Africa holds the low share for this market. However, the rising healthcare awareness at the hospital and in the community are expected to influence the market positively.

Key Players

Some of the key players in the global ultrasound probe disinfection market are STERIS (UK), Nanosonics (Australia), Tristel (UK), Ecolab (US), Schülke & Mayr (Germany), Advanced Sterilization Products (US), CIVCO Medical Solutions (US), Germitec (France), Parker Laboratories (US), CS Medical (US), Virox Technologies (Canada), and Metrex Research (US).

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/ultrasound-probe-disinfection-market-6642